Literature DB >> 25855665

Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.

Alexander D J Baur1, Marianne Pavel2, Vikas Prasad3, Timm Denecke3.   

Abstract

Pancreatic neuroendocrine neoplasms (pNEN) are rare malignancies arising from neuroendocrine cells of the pancreas. Functional tumors can present with specific clinical syndromes due to hormonal secretion. These tumors can present as incidental findings on imaging performed for unrelated purposes or they are diagnosed when workup is initiated in patients with specific syndromes or metastases. This article presents an overview of available imaging techniques focusing on computed tomography and magnetic resonance imaging. Recommendations regarding examination protocols are given. Typical imaging features of pNEN and metastases are described. Their potential value for the evaluation of prognosis as well as tumor response under treatment is discussed. © The Foundation Acta Radiologica 2015.

Entities:  

Keywords:  Neuroendocrine neoplasm; computed tomography (CT); detection; magnetic resonance imaging (MRI); staging; treatment response

Mesh:

Year:  2015        PMID: 25855665     DOI: 10.1177/0284185115579932

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  8 in total

Review 1.  Flushing in (neuro)endocrinology.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 2.  State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors.

Authors:  Eric P Tamm; Priya Bhosale; Jeffrey H Lee; Eric M Rohren
Journal:  Surg Oncol Clin N Am       Date:  2016-04       Impact factor: 3.495

3.  Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors.

Authors:  Yijing Xie; Shipeng Zhang; Xianwang Liu; Xiaoyu Huang; Qing Zhou; Yongjun Luo; Qian Niu; Junlin Zhou
Journal:  Jpn J Radiol       Date:  2022-03-14       Impact factor: 2.701

4.  Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

Authors:  V Polenta; E P Slater; P H Kann; M B Albers; J Manoharan; A Ramaswamy; A H Mahnken; D K Bartsch
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

5.  A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.

Authors:  Yong Gao; Hao Gao; Guangfu Wang; Lingdi Yin; Wenbin Xu; Yunpeng Peng; Junli Wu; Kuirong Jiang; Yi Miao
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

6.  Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms.

Authors:  Shengming Deng; Zhiyao Fan; Huanyu Xia; Yitao Gong; Yunzhen Qian; Qiuyi Huang; He Cheng; Kaizhou Jin; Zhiwen Xiao; Guopei Luo; Xianjun Yu; Chen Liu
Journal:  Cancer Manag Res       Date:  2021-01-08       Impact factor: 3.989

7.  Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors.

Authors:  Michail Papamichail; Amir Ali; Michail Pizanias; Praveen Peddu; John Karani; Nigel Heaton
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

8.  Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.

Authors:  Shuai Ren; Xiao Chen; Zhonglan Wang; Rui Zhao; Jianhua Wang; Wenjing Cui; Zhongqiu Wang
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.